Gangloff Scott A. bought AKRO

August 15, 2025 · Form 4 insider transaction

Gangloff Scott A. bought 2,600 shares of Akero Therapeutics, Inc. at $19.62 per share, a transaction worth $51.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
2,600
Price
$19.62
Total value
$51.0K
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 15, 2025
Filing dateAugust 19, 2025
Shares owned after26,351
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR